The key equity indices managed to pare some losses and came off the days low in mid-afternoon trade. The Nifty traded tad below the 16,450 level. Auto shares witnessed sharp sell-off. At 14:25 IST, the barometer index, S&P BSE Sensex tumbled 740.98 points or 1.33% to 54,961.25. The Nifty 50 index lost 233.70 points or 1.40% to 16,448.95. Investor sentiment were dented on concerns that […]
The pharmaceutical company announced that its subsidiary, Zydus Worldwide DMCC secured a tentative approval from the US-based drug regulatory body, United States Food and Drug Administration (USFDA) to market Selexipag tablets.
Sales rise 370.00% to Rs 0.47 crore
Company all set to post a good performance in the quarter.
Total Operating Income rise 4.85% to Rs 3686.30 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
